Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
11/01/2011 | US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use |
11/01/2011 | US8048670 Synthetic genes and genetic constructs |
11/01/2011 | US8048665 Nucleotide sequences encoding alanine racemase from coryneform |
11/01/2011 | US8048664 Polynucleotides encoding modified DNA cleavage enzymes and host cells therefor |
11/01/2011 | US8048663 Crystal of pregnane X receptor fused to steroid receptor coactivator-1 |
11/01/2011 | US8048662 Sulfotransferase 1E1 sequence variants |
11/01/2011 | US8048661 Microbial organisms comprising exogenous nucleic acids encoding reductive TCA pathway enzymes |
11/01/2011 | US8048657 Enzyme compositions comprising a glucoamylase, an acid stable alpha amylase, and an acid fungal protease |
11/01/2011 | US8048653 Microbial oils produced in transformed host cells comprising delta-9 elongases |
11/01/2011 | US8048651 Methods for the preparation of lysine by fermentation of Corynebacterium glutamicum |
11/01/2011 | US8048649 Production of amino acids from sucrose in Corynebacterium glutamicum |
11/01/2011 | US8048647 Aldolase, and method for producing optically active IHOG and monatin |
11/01/2011 | US8048642 Heme choline esters and uses thereof |
11/01/2011 | US8048415 Compositions and methods for promoting or inhibiting angiogenesis |
11/01/2011 | US8048412 Enzyme with microbial lysis activity from Trichoderma reesei |
11/01/2011 | CA2604143C Methods for detecting thyroid carcinoma cells |
11/01/2011 | CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds |
11/01/2011 | CA2404938C Production of polyketides |
11/01/2011 | CA2337967C Recombinant uricase protein |
11/01/2011 | CA2245818C Modification of polysaccharides |
11/01/2011 | CA2224626C Expression system employing a xylanolytic transcriptional activator |
11/01/2011 | CA2221192C Embedded expression of heterologous proteins |
10/27/2011 | WO2011133960A2 Lysosomal storage disease enzyme |
10/27/2011 | WO2011133571A2 Digestible lignocellulosic biomass and extractives and methods for producing same |
10/27/2011 | WO2011133559A2 Alpha tubulin acetyltransferase |
10/27/2011 | WO2011133504A2 Nanozymes, methods of making nanozymes, and methods of using nanozymes |
10/27/2011 | WO2011133111A1 Trichoderma viride strain for cellulolytic enzyme production |
10/27/2011 | WO2011132444A1 Modified carbonyl reductase, gene thereof, and method of producing optically active alcohols using these |
10/27/2011 | WO2011132392A1 Method for assaying histone methylation enzyme activity |
10/27/2011 | WO2011131980A1 Assay for identification of lrrk2 inhibitors |
10/27/2011 | WO2011131736A1 Method for producing recombinant thrombin |
10/27/2011 | WO2011131720A1 New stabilizing agent for pharmaceutical proteins |
10/27/2011 | WO2011131626A1 Tmem195 encodes for tetrahydrobiopterin-dependent alkylglycerol monooxygenase activity |
10/27/2011 | WO2011109524A3 Xylanase variants and polynucleotides encoding same |
10/27/2011 | WO2011097590A3 High fidelity restriction endonucleases |
10/27/2011 | WO2011084455A3 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1 |
10/27/2011 | WO2011049418A9 Novel ginsenoside glycosidase derived from the genus terrabacter, and use thereof |
10/27/2011 | WO2011028623A3 Modified organisms for improved saccharification of biomass |
10/27/2011 | WO2010091149A8 Modification of multidomain enzyme for expression in plants |
10/27/2011 | US20110265198 Genome editing of a Rosa locus using nucleases |
10/27/2011 | US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof |
10/27/2011 | US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof |
10/27/2011 | US20110265194 Them5-modified models of non-alcoholic fatty liver disease |
10/27/2011 | US20110263839 Nucleic Acids Encoding Nitrilases |
10/27/2011 | US20110263690 Methods and Compositions for use in Gene Therapy for Treatment of Hemophilia |
10/27/2011 | US20110263689 AKT Ligands and Polynucleotides Encoding AKT Ligands |
10/27/2011 | US20110263639 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
10/27/2011 | US20110263581 Fused tricyclic compounds as serine-threonine protein kinase and parp modulators |
10/27/2011 | US20110263499 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants |
10/27/2011 | US20110263487 Plant Production and Delivery System for Recombinant Proteins as Protein-Flour or Protein-Oil Compositions |
10/27/2011 | US20110263435 Genetic markers for boar taint |
10/27/2011 | US20110263000 A thrombin-like enzyme of agkistrodon acutus |
10/27/2011 | US20110262999 Compositions and Methods Comprising Protease Variants |
10/27/2011 | US20110262998 Process for preparing inclusion body-forming protein |
10/27/2011 | US20110262997 Production of cellulase |
10/27/2011 | US20110262996 Methods and materials for degrading pyrethroid |
10/27/2011 | US20110262995 GRG32: A Novel EPSP Synthase Gene Conferring Herbicide Resistance |
10/27/2011 | US20110262994 Novel reagents and method for conjugating biological molecules |
10/27/2011 | US20110262993 Method for preparing a cellular carbon monolith comprising a hierarchised porous network |
10/27/2011 | US20110262992 Method for stabilizing labeled antibody |
10/27/2011 | US20110262991 Living Copolymer-Protein/Peptide Hybrids for Biomedical Applications |
10/27/2011 | US20110262988 Methods and compositions for enhanced bacterial hydrolysis of cellulosic feedstocks |
10/27/2011 | US20110262978 Expression vector for pseudonocardia autotrophica |
10/27/2011 | US20110262977 Process for production of optically active amine derivative |
10/27/2011 | US20110262974 Novel enzymes for use in enzymatic bleaching of food products |
10/27/2011 | US20110262973 Methods and Compositions for DNA Manipulation |
10/27/2011 | US20110262972 Chondroitin Synthase, Method for Producing the Same and Method for Producing Saccharide Chain-Extended Chondroitin |
10/27/2011 | US20110262970 Enzymatic Hydrolysis Of Pretreated Lignocellulose-Containing Material With Cationic Polysaccharides |
10/27/2011 | US20110262963 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues |
10/27/2011 | US20110262954 Shuttle vector based transformation system for pyrococcus furiosus |
10/27/2011 | US20110262929 Anti-hs6st2 antibodies and uses thereof |
10/27/2011 | US20110262619 Polypeptide having phytase activity and increased temperature resistance of the enzyme activity, and nucleotide sequence coding said polypeptide |
10/27/2011 | US20110262591 Lipases with high specificity towards short chain fatty acids and uses thereof |
10/27/2011 | US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses |
10/27/2011 | US20110262481 High growth reassortant influenza a virus |
10/27/2011 | US20110262476 Mutant bacterial glycoproteins and uses thereof |
10/27/2011 | US20110262451 Modulators of isovaleryl-coenzyme a dehydrogenase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
10/27/2011 | US20110262450 Modulators of monoglyceride lipase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
10/27/2011 | US20110262437 Use of erbb4 as a prognostic and therapeutic marker for melanoma |
10/27/2011 | US20110262429 Human timp-1 antibodies |
10/27/2011 | US20110262424 Recombinantly produced human factor viii and ix |
10/27/2011 | US20110262423 Suppression of cancer |
10/27/2011 | US20110262422 Orally administrable dosage forms comprising angiogenin and uses thereof |
10/27/2011 | US20110262420 Inhalant comprising modified superoxide dismutase |
10/27/2011 | US20110262419 Specifically targeted catalytic antagonists and uses thereof |
10/27/2011 | US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
10/27/2011 | US20110262353 Muteins of hngal and related proteins with affinity for a given target |
10/27/2011 | DE102010028008A1 Modifying substrate specificity of polyol oxidase, comprises providing the polyol oxidase comprising specified amino acid sequences and introducing specified amino acid substitutions in the polyol oxidase |
10/27/2011 | CA2796729A1 New stabilizing agent for pharmaceutical proteins |
10/27/2011 | CA2796607A1 Lysosomal storage disease enzyme |
10/27/2011 | CA2795535A1 Method for producing recombinant thrombin |
10/26/2011 | EP2381586A1 Spread spectrum meter reading system utilizing low speed frequency hopping |
10/26/2011 | EP2380989A1 Method and reagent for determining mevalonic acid, 3-hydroxymethylglutaryl-coenzyme a and coenzyme a |
10/26/2011 | EP2380985A1 Cells expressing vitamin K epoxide reductase and use thereof |
10/26/2011 | EP2380982A1 Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
10/26/2011 | EP2380981A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
10/26/2011 | EP2380980A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
10/26/2011 | EP2380975A1 Method for producing recombinant thrombin |
10/26/2011 | EP2380911A1 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
10/26/2011 | EP2380910A1 Antigen binding molecules with increased Fc receptor binding affinity and effector function |